Sandra Milligan - May 14, 2024 Form 3 Insider Report for Spyre Therapeutics, Inc. (SYRE)

Role
Director
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
Stock symbol
SYRE
Transactions as of
May 14, 2024
Transactions value $
$0
Form type
3
Date filed
5/16/2024, 04:05 PM
Previous filing
May 6, 2024
Next filing
Jun 6, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney